Home LiteratureArticle Details
PMID: 2179631 Published · ppublish English Case Reports Journal Article Review

Dormancy and breast cancer.

Journal of surgical oncology ·Vol. 43 ·No. 3 ·1990-03-00 ·Pages 181-8

Meltzer A

Abstract

A case is presented in which multiple nodules of recurrent cancer appeared about the scar 25 years after radical mastectomy. They were accompanied by an inflammatory reaction. Breast cancers may recur as long as 50 years after surgery. Such late recurrence is accomplished by the cancer cell entering a "dormant" state in which little or no de novo DNA transcription occurs and only enough RNA is translated into proteins to maintain the vegetative functions that sustain cell viability. Features favoring the evolvement of dormancy are discussed as well as the nature of the cocoon-like shell which affords such cancer cells protection from the host's cellular and serological defenses. Speculation, promoted by the new cellular biology, as to the cause of secondary inflammatory cancers, is presented. A possible mechanism for the reactivation of these quiescent cells is suggested. The altered immune reactions of host and cancer cells provide an explanation for the controversies plaguing surgeons regarding the treatment and prognosis of breast cancer.

MeSH Terms
Breast Neoplasms/physiopathology,surgery Female Humans Neoplasm Recurrence, Local/immunology,physiopathology Risk Factors Time Factors
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Meltzer A
Department of Surgery, University of Massachusetts Medical School, Worcester 01609.
Article Info
Journal
Journal of surgical oncology
Abbr.
J Surg Oncol
ISSN
0022-4790
Published
1990-03-00
Pages
181-8
Language
English
Region
United States
NLM ID
0222643
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com